{
Glaxosmithkline plc

Companies

}
001122334455554433221100
001122334455554433221100

gsk reports strong year-end results and raises sales targets to 2031

GSK reported a strong fiscal year with a 7% increase in currency-adjusted revenue, reaching £31 billion, driven by growth in cancer treatments and innovative medicines. The company raised its sales targets to 2031 and announced a £2 billion share buyback over the next 18 months. Analysts have varied ratings for GSK, with Bernstein maintaining an 'Outperform' at a target of 2355 pence, while Deutsche Bank holds a 'Hold' rating with a target of 1450 pence.
aktiencheck.de
British Pound Sterling Glaxosmithkline plc CHN USA GBR James Gordon Luisa Hector Emmanuel Papadakis Peter Welford Rajan Sharma Florent Cespedes Show more
Business & Industry, Market Report
07:14 06.02.2025

healthy foods market poised for significant growth driven by consumer demand

The Healthy Foods Market, valued at USD 712.2 billion in 2023, is projected to grow significantly due to rising health awareness and demand for nutrient-rich, organic, and plant-based products. Key players include Nestle, Danone, and PepsiCo, as the market adapts to trends like personalized nutrition and technology integration in food delivery. Challenges such as high production costs and consumer preferences for traditional foods persist, but opportunities for growth remain robust across various regions.
openPR.com
United States Dollar The Kraft Heinz Company Mondelez International Inc Archer-Daniels-Midland Company Glanbia PLC PepsiCo Inc Nestle SA Dairy Farmers OF America Inc. General Mills Inc Herbalife Nutrition Ltd Glaxosmithkline plc Yakult Honsha Co Ltd Abbott Laboratories Danone S.A. FRA CHL TUR SAU RUS IND AUS ESP GBR AUT BEL COL DEU POL NGA ARG ARE CAN NZL USA MAR ZAF ISR NLD SGP BRA QAT CHN MEX ITA TWN JPN TUN KOR Show more
Healthcare, Market Report
09:18 07.01.2025

semaglutides market projected to reach 36.87 billion by 2028

The semaglutides market is projected to grow from $20.54 billion in 2023 to $36.87 billion by 2028, driven by rising diabetes prevalence and increased demand for effective treatments. Key players are innovating with GLP-1 receptor analogues and oral formulations to enhance patient adherence and reduce side effects. North America leads the market, while Asia-Pacific is expected to be the fastest-growing region.
GlobeNewswire News Room
United States Dollar Adocia SA Sanofi SA Eli Lilly and Company Roche Holding AG Pfizer Inc. Merck & Co., Inc. Dr. Reddy's Laboratories Limited Boehringer Ingelheim International GmbH Glaxosmithkline plc Takeda Pharmaceutical Company Limited AbbVie Inc. Novartis International AG Bristol-Myers Squibb Company Novo Nordisk A/S Cipla Limited Biocon Limited Teva Pharmaceutical Industries Ltd AstraZeneca PLC Amgen Inc. ITA IND FRA IDN CAN ESP BRA USA RUS CHN DEU AUS JPN GBR KOR Show more
Healthcare, Market Report
10:12 06.01.2025

topical corticosteroids market poised for growth with emerging opportunities and trends

The global Topical Corticosteroids market, valued at approximately US$ 4.12 billion in 2022, is projected to grow at a CAGR of 4.36% through 2030. The report provides an extensive analysis of market dynamics, competitive landscape, and consumption trends, highlighting key players like GlaxoSmithKline and Merck & Co. It also explores opportunities for growth driven by increasing demand across various industries, while addressing challenges such as supply chain disruptions and changing consumer preferences.
openPR.com
Merck & Co., Inc. AstraZeneca PLC Almirall S.A. A Bristol-Myers Squibb Company Glaxosmithkline plc Leo Pharma AB Bausch Health Companies Inc. IND GBR CAN SAU JPN BRA DEU FRA MEX CHN USA Viju Shah Alice Mutum Show more
Healthcare, Market Report
11:04 13.12.2024

preventive healthcare technologies market poised for significant growth by 2028

The preventive healthcare technologies and services market is projected to grow from $259.84 billion in 2023 to $541.36 billion by 2028, driven by an aging population and advancements in digital health. Key players are innovating with advanced preventative care programs, such as WELL Longevity+, which integrates AI and diagnostic imaging to enhance early intervention strategies.
openPR.com
McKesson Corporation Alere Inc. Omnicell Inc Medtronic plc Merck & Co., Inc. Walgreens Boots Alliance Inc Quest Diagnostics Incorporated Cerner Corporation Glaxosmithkline plc Myriad Genetics Inc Healthways Inc. Teladoc Health Inc Pfizer Inc. ModivCare Inc. Vocera Communications Inc. Novartis AG Tivity Health Inc. Sanofi SA Change Healthcare Inc. Allscripts Healthcare Solutions Inc GRAIL Inc Show more
Healthcare, Market Report
11:23 09.12.2024

frontotemporal dementia market growth trends and future projections 2024 to 2031

The Global Frontotemporal Dementia Market is projected to grow from USD 12.19 billion in 2024 to USD 18.21 billion by 2031, at a CAGR of 5.9%. Key players include Johnson & Johnson, Sanofi S.A., and Eli Lilly, with insights into market trends, competitive landscape, and future growth opportunities detailed in a comprehensive report.
openPR.com
United States Dollar Novartis AG Sanofi Mylan N.V. Merck & Co., Inc. Glaxosmithkline plc Eli Lilly and Company USA Priya Pandey Viju Shah Show more
Healthcare, Market Report
13:42 27.11.2024

consumer healthcare market poised for rapid growth driven by digital innovations

The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024

global hashimoto thyroiditis market projected to reach 12.6 billion by 2033

The global Hashimoto"s thyroiditis market is projected to grow from $8.3 billion in 2023 to $12.6 billion by 2033, with a CAGR of 4.26%. North America is expected to dominate the market, while Asia-Pacific will experience the fastest growth due to rising healthcare awareness and improved infrastructure. The tablet segment will hold the largest market share, driven by convenience and patient compliance.
Spherical Insights
United States Dollar Amgen Inc. Merck & Co., Inc. Novartis AG Sanofi Mylan N.V. Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Company Takeda Pharmaceuticals Limited Company Bayer AG Pfizer Inc. Roche Holding AG AbbVie Inc. AstraZeneca PLC Eli Lilly and Company Glaxosmithkline plc ARG GBR FRA ITA KOR ZAF MEX USA BRA ESP SAU CAN QAT ARE JPN AUS DEU CHN RUS IND Pfizer Inc. AbbVie Inc. Mylan N.V. Inc. Merck & Co GlaxoSmithKline plc Show more
Healthcare, Market Report
04:38 19.11.2024

global consumer health market projected to reach over 713 billion by 2033

The global consumer healthcare market is segmented by product types, including OTC pharmaceuticals, personal care products, and dietary supplements, with offline distribution channels expected to dominate. North America is projected to lead the market due to rising awareness of wellness products, while Asia Pacific is anticipated to grow rapidly, driven by increasing disposable incomes and a large elderly population. Key players include Johnson & Johnson, Procter and Gamble, and Pfizer, among others, with ongoing developments enhancing market dynamics.
Spherical Insights
United States Dollar Johnson & Johnson Colgate-Palmolive Company Bayer AG Merck & Co., Inc. Boehringer Ingelheim GmbH Nestlé S.A. Mylan N.V. Reckitt Benckiser Group plc Novartis International AG Glaxosmithkline plc Eli Lilly and Company Perrigo Company plc Sanofi Teva Pharmaceutical Industries Ltd. Abbott Laboratories Pfizer Inc. Procter and Gamble ESP IND QAT GBR JPN KOR AUS ARE CHN DEU USA BRA RUS MEX CAN ARG ITA SAU ZAF Brian Johnson Mylan Nv Show more
Healthcare, Market Report
18:35 18.11.2024

global bile duct cancer market analysis and growth prospects through 2030

The bile duct cancer market is expanding, driven by a shortage of specialists and healthcare system challenges in developing countries. In 2021, North America led the market with a 37.1% share and $185.4 billion in revenue, fueled by increased R&D and rising cancer prevalence. The Asia-Pacific region is projected to grow the fastest through 2030, supported by awareness programs and private investments.
Spherical Insights
United States Dollar Glaxosmithkline plc Pfizer Inc. Novartis AG Fresenius Kabi AG AbbVie Inc. RUS GBR ITA ESP USA KOR SAU JPN MEX ARE ZAF BRA ARG CHN QAT AUS IND DEU CAN Eli Lilly GlaxoSmithKline plc Pfizer Inc. Novartis AG AbbVie Inc. Show more
Healthcare, Market Report
22:25 28.10.2024
Trending
Subcategory
Industry Trends Startups & Entrepreneurship Corporate News Supply Chain Management Global Trade Developments Private Equity Deals Retail and Consumer Goods Government Economic Policies CEO Changes Industry Mergers & Acquisitions Workplace Trends Stock Market Updates Corporate Social Responsibility Emerging Startups Consumer Protection Regulations Fintech Startups Energy Sector Developments Venture Capital Investments Funding Rounds & Investments Finance Mergers & Acquisitions
Countries:
USA IND CHN ARE SAU JPN SGP GBR EGY IDN KOR TWN QAT MYS DEU VNM NGA HKG BRA MEX
Companies:
Apple Inc. NVIDIA Corporation Google Inc. Amazon.com, Inc. Tesla, Inc. JD.com, Inc. Toyota Motor Corp Honda Motor Co., Ltd. Microsoft Corporation The Goldman Sachs Group, Inc. Samsung Securities Co.,Ltd. Meituan XIAOMI-W Tesmec S.p.A. TENCENT Emirates NBD Bank PJSC Orange S.A. Boeing Co Salesforce, Inc. Foxconn Technology Co., Ltd.
Currencies:
United States Dollar Chinese Yuan Indian Rupee Euro Japanese Yen British Pound Sterling Saudi Riyal Offshore Chinese Yuan Indonesian Rupiah Vietnamese Đồng South Korean Won Nigerian Naira Nicaraguan Córdoba New Taiwan Dollar Qatari Riyal Mexican Peso Pakistani Rupee Malaysian Ringgit Singapore Dollar Macanese Pataca
People:
Donald Trump Tim Cook Mark Zuckerberg Haider Ali Khan Ayman Hamdan Bisrat Degefa Xi Jinping Jensen Huang Piyush Anchliya Stiven Muccioli Tamim bin Hamad Al Thani Pandu Sjahrir Prabowo Subianto Ray Dalio Changpeng Zhao Prashant Joshi Amal El Fallah Seghrouchni Ahmed Hamdan He Xiaopeng Abdel Fattah El-Sisi

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.